Synthesis of chiral kynurenine compounds and intermediates

A compound, chiral phosphine ligand technology, applied in the field of synthetic compounds, can solve problems such as low solubility and no success

Inactive Publication Date: 2015-12-16
VISTAGEN THERAPEUTICS INC
View PDF5 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, experiments to separate the enantiomers by crystallization of diastereomeric salts were unsuccessful, and separation by preparative high-performance liquid chromatography (HPLC) was largely unsuccessful due to low solubility.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Synthesis of chiral kynurenine compounds and intermediates
  • Synthesis of chiral kynurenine compounds and intermediates
  • Synthesis of chiral kynurenine compounds and intermediates

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0160] Preparation of Z-α-acetamido-6-chloroindole-3-propenoic acid ethyl ester

[0161] Add 6-chloroindole-3-carbaldehyde (530 g, 2.95 mol), ethyl acetamidomalonate (837 g, 4.42 mol, 1.50 eq) and pyridine (2650 mL) into a 5 L 3-neck round bottom flask and stir and heated to 25°C until a clear solution formed. The resulting solution was cooled to -5°C and acetic anhydride (964 g, 9.44 mol, 3.20 equiv) was added slowly over 3-4 hours at 12. TLC monitoring (100% ethyl acetate) showed complete conversion of the N-acylated product to the desired product after stirring for 4 hours. Concentrated HCl (130 mL) was added to the slurry to adjust the pH to 5-6. The product was then filtered, washed with water and then 3 times with methyl tert-butyl ether (MTBE). 10.6 g of product were dried in a vacuum oven at 45°C and <10 mm Hg. Yield of ethyl Z-[alpha]-acetamido-6-chloroindole-3-propenoate: 407 g (1.33 mol, 45% yield, 74% corrected for recovered starting material). HPLC: 97.4% che...

example 2

[0164] Preparation of (S)-ethyl 2-acetamido-3-(6-chloro-1H-indol-3-yl)propionate

[0165] Ethyl Z-α-acetamido-6-chloroindole-3-propenoate (434 g, 1.41 mol) was dissolved in methanol at 60 °C, analytically pure (AR = anhydrous reagent grade, 6510 mL) to form a light yellow solution. The solution was then cooled to room temperature and charged to a 20 L hydrogenator. The hydrogenator was purged three times with 25 psi nitrogen and allowed to stir for 20 minutes under 25 psi nitrogen to remove any dissolved oxygen from the reaction mixture. The hydrogenator is then discharged and the chiral catalyst [(S,S',R,R')-DuanPhosRh(COD)][BF 4 ] (0.93 g, 0.0014 mol, 0.001 equiv) was added to the reaction mixture. The hydrogenator was pressurized with 30 psi of hydrogen and stirred for 10 minutes. The gas is then vented and the procedure repeated two more times. The hydrogenator was re-pressurized with 90 psi hydrogen and stirred overnight at room temperature. Periodically repressuriz...

example 3

[0168] Preparation of (2S)-2-(acetamido)-4-(2-carbonylamino-4-chlorophenyl)-4-oxobutanoic acid ethyl ester

[0169] Into a 50 gallon reactor was charged (S)-ethyl 2-acetamido-3-(6-chloro-1H-indole-3- base) propionate (3000 g, 9.716 mol), heated to 30°C to give a clear solution, then cooled to -20°C and stirred at maximum stirring speed. The pH of the solution was 10.0. A solution of MCPBA (4785 g, 27.73 mol, 2.854 equiv) in THF (2.5 L) and DCM (15 L) was prepared and added to a 20 L addition funnel. At the same time, a solution of sodium carbonate (2265 g) in water (12 L) was added to a second 20 L addition funnel. The MCPBA solution was added at a rate to maintain the temperature <-15°C. Once the reaction mixture reached a pH of 3-4, sodium carbonate solution was added to maintain the pH of the reaction mixture at 3-6. Once both solutions were added to the reactor, the progress of the reaction was checked by spotting the organic layer on a TLC plate. In 100% ethyl acetat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Provided are methods for the synthesis of compounds including chiral kynurenine compounds, intermediates useful for the synthesis thereof, and related compounds. For example, methods are provided for the synthesis of L-4-chlorokynurenine.

Description

[0001] Cross References to Related Applications [0002] This application claims priority to US Provisional Patent Application Serial No. 61 / 785,815, filed March 14, 2013, the disclosure of which is incorporated herein by reference in its entirety. technical field [0003] The present invention relates to a method for synthesizing compounds, wherein the compounds include chiral kynurenine compounds, their synthetic intermediates and related compounds. Background technique [0004] Kynuric acid is a brain component metabolized with anticonvulsant and neuroprotective properties (Stone, T.W.; Pharmacol. Rev. 1993, 45, 309-379). The biological activities of kynurenic acid and various derivatives of its kynurenine precursors have been studied (Camacho, E. et al. J. Med. Chem. 2002, 45, 263-274; Varasi, M. et al. Eur. J. Med. Chem. 1996, 31, 11-21; Salituro, F.G. et al. J. Med. Chem. 1994, 37, 334-336). The kynurenine compound is converted in the body to kynurenic acid. US Pate...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C51/36
CPCC07C227/12C07C231/10C07C227/18C07C227/20C07C231/12C07D209/20C07C229/42C07D209/42A61P21/02A61P25/00A61P25/08C07C233/47
Inventor 亚历山大·特列季亚科夫基思·E·德罗埃特威廉·桑德斯
Owner VISTAGEN THERAPEUTICS INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap